THERAPEUTIC AGENT FOR CARTILAGE DISEASE

The present disclosure addresses the problem of providing a novel therapeutic agent, for cartilage disease, that has cartilage-regenerating action. Because substances having SIK2 inhibitory action have chondrocyte-differentiation-inducing action, a therapeutic agent formed so as to contain a substan...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TSUMORI, Yuki, NAKANISHI, Yasutomo, FUJIMURA, Shinsei
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure addresses the problem of providing a novel therapeutic agent, for cartilage disease, that has cartilage-regenerating action. Because substances having SIK2 inhibitory action have chondrocyte-differentiation-inducing action, a therapeutic agent formed so as to contain a substance having SIK2-inhibitory action is useful as a therapeutic agent, having cartilage-regenerating action, for cartilage damage or cartilage diseases such as osteoarthritis.